Published in Nucleic Acids Res on August 25, 1991
DNA testing for fragile X syndrome in schools for learning difficulties. Arch Dis Child (1995) 1.98
Instability versus predictability: the molecular diagnosis of myotonic dystrophy. J Med Genet (1992) 1.94
A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. Am J Hum Genet (1992) 1.73
Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet (1993) 1.71
Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap. Am J Hum Genet (1994) 1.51
Genotype prediction in the fragile X syndrome. J Med Genet (1991) 1.45
Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation. J Med Genet (1993) 1.40
Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data. Am J Hum Genet (1994) 1.11
Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats. J Med Genet (1998) 1.11
Two new cases of FMR1 deletion associated with mental impairment. Am J Hum Genet (1995) 1.08
A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United Kingdom. Am J Hum Genet (1996) 1.06
Presymptomatic diagnosis of myotonic dystrophy. J Med Genet (1992) 1.02
High-resolution genetic map around the spinal muscular atrophy (SMA) locus on chromosome 5. Am J Hum Genet (1992) 0.97
Characterization of FMR1 promoter elements by in vivo-footprinting analysis. Am J Hum Genet (1997) 0.95
Anticipation legitimized: unstable DNA to the rescue. Am J Hum Genet (1992) 0.91
Origins of the fragile X syndrome mutation. J Med Genet (1993) 0.91
Interruption of the fragile X syndrome expanded sequence d(CGG)(n) by interspersed d(AGG) trinucleotides diminishes the formation and stability of d(CGG)(n) tetrahelical structures. Nucleic Acids Res (2000) 0.89
Clinical, cytogenetic, and molecular analysis of three families with FRAXE. J Med Genet (1997) 0.81
Variant mapping of the Apo(B) AT rich minisatellite. Dependence on nucleotide sequence of the copy number variations. Instability of the non-canonical alleles. Nucleic Acids Res (1993) 0.81
Direct analysis of the FMR-1 gene provides an explanation for an exceptional case of a fragile X negative, mentally retarded male in a fragile X family. J Med Genet (1992) 0.79
Expansion and methylation status at FRAXE can be detected on EcoRI blots used for FRAXA diagnosis: analysis of four FRAXE families with mild mental retardation in males. Am J Hum Genet (1996) 0.78
Fragile X Syndrome: Scientific Background and Screening Technologies. J Mol Diagn (2015) 0.77
Development of Genetic Testing for Fragile X Syndrome and Associated Disorders, and Estimates of the Prevalence of FMR1 Expansion Mutations. Genes (Basel) (2016) 0.75
Direct versus indirect molecular diagnosis of fragile X mental retardation in 40 German families at risk. J Med Genet (1993) 0.75
FRAXF in a patient with chromosome 8 duplication. J Med Genet (1996) 0.75
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell (1991) 17.00
A marker X chromosome. Am J Hum Genet (1969) 4.68
Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. Science (1977) 4.59
Physical mapping across the fragile X: hypermethylation and clinical expression of the fragile X syndrome. Cell (1991) 3.98
Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet (1985) 3.42
The marker (X) syndrome: a cytogenetic and genetic analysis. Ann Hum Genet (1984) 3.17
Abnormal pattern detected in fragile-X patients by pulsed-field gel electrophoresis. Nature (1991) 2.13
The frequency of the fragile X chromosome among schoolchildren in Coventry. J Med Genet (1986) 2.06
A premutation that generates a defect at crossing over explains the inheritance of fragile X mental retardation. Am J Med Genet (1985) 1.83
Prevalence of the fragile X syndrome in four birth cohorts of children of school age. Hum Genet (1987) 1.32
A YAC contig across the fragile X site defines the region of fragility. Nucleic Acids Res (1991) 1.29
Recombination and amplification of pyrimidine-rich sequences may be responsible for initiation and progression of the Xq27 fragile site: an hypothesis. Am J Med Genet (1986) 1.19
Linear order of new and established DNA markers around the fragile site at Xq27.3. Genomics (1991) 1.00
Unusual presentation of fragile X syndrome. Lancet (1990) 0.85
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Rapid evolution of RNA genomes. Science (1982) 14.76
A gene map of the human genome. Science (1996) 14.32
The Biomolecular Interaction Network Database and related tools 2005 update. Nucleic Acids Res (2005) 12.94
The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med (2001) 11.48
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med (1999) 9.84
Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol (2003) 9.10
The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature (1993) 7.39
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias. N Engl J Med (2013) 6.67
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
A systematic, high-resolution linkage of the cytogenetic and physical maps of the human genome. Nat Genet (2000) 4.78
Dynamic association of capping enzymes with transcribing RNA polymerase II. Genes Dev (2000) 4.47
Proteolysis that is inhibited by hedgehog targets Cubitus interruptus protein to the nucleus and converts it to a repressor. Cell (1997) 4.43
Rapid fitness losses in mammalian RNA virus clones due to Muller's ratchet. Proc Natl Acad Sci U S A (1992) 4.22
Sexual health education interventions for young people: a methodological review. BMJ (1995) 4.18
What is the best similarity measure for motion correction in fMRI time series? IEEE Trans Med Imaging (2002) 4.09
Physical mapping across the fragile X: hypermethylation and clinical expression of the fragile X syndrome. Cell (1991) 3.98
Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A (2001) 3.86
Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics J (2005) 3.75
The osmotic pressure of globin. Biochem J (1932) 3.69
Three functional classes of transcriptional activation domain. Mol Cell Biol (1996) 3.62
The unmet health needs of America's children. Pediatrics (2000) 3.45
Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet (1985) 3.42
Clinical studies on submicroscopic subtelomeric rearrangements: a checklist. J Med Genet (2001) 3.28
A randomized controlled trial of surgery vs steroid injection for carpal tunnel syndrome. Neurology (2005) 3.26
Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging (2001) 3.25
High-resolution random mesh algorithms for creating a probabilistic 3D surface atlas of the human brain. Neuroimage (1996) 2.99
Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature (1991) 2.87
Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart (2002) 2.83
Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg (1992) 2.76
Mechanical function of dystrophin in muscle cells. J Cell Biol (1995) 2.67
Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol (1992) 2.63
Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol (1998) 2.59
Three-dimensional multimodal brain warping using the demons algorithm and adaptive intensity corrections. IEEE Trans Med Imaging (2001) 2.58
Disoriented pathfinding by pioneer neurone growth cones deprived of filopodia by cytochalasin treatment. Nature (1986) 2.57
Genetic bottlenecks and population passages cause profound fitness differences in RNA viruses. J Virol (1993) 2.55
A SNP resource for human chromosome 22: extracting dense clusters of SNPs from the genomic sequence. Genome Res (2001) 2.49
Three-dimensional statistical analysis of sulcal variability in the human brain. J Neurosci (1996) 2.47
Evidence of founder chromosomes in fragile X syndrome. Nat Genet (1992) 2.38
During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg (1999) 2.37
Physical mapping studies on the human X chromosome in the region Xq27-Xqter. Genomics (1987) 2.35
Acoustic characteristics of English fricatives. J Acoust Soc Am (2000) 2.30
Comparative studies of psychological function in patients with advanced cancer--I. Self-reported depressive symptoms. Psychosom Med (1977) 2.28
Accumulation of enoxacin by Escherichia coli and Bacillus subtilis. Antimicrob Agents Chemother (1987) 2.26
Agriculture. Increased food and ecosystem security via perennial grains. Science (2010) 2.25
Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet (1997) 2.19
Health literacy and shared decision making for prostate cancer patients with low socioeconomic status. Cancer Invest (2001) 2.16
Behavioural interventions for HIV/AIDS prevention. AIDS (1995) 2.10
Primary structure of dystrophin-related protein. Nature (1992) 2.09
Determinants of the willingness to endorse assisted suicide. A survey of physicians, nurses, and social workers. Psychosomatics (1997) 2.06
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol (2000) 1.95
Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrob Agents Chemother (1995) 1.94
CACNA1C (rs1006737) is associated with schizophrenia. Mol Psychiatry (2010) 1.93
The guanylyltransferase domain of mammalian mRNA capping enzyme binds to the phosphorylated carboxyl-terminal domain of RNA polymerase II. J Biol Chem (1998) 1.91
The use of alternative therapies by Auckland general practitioners. N Z Med J (1990) 1.89
Sexually transmitted diseases in homosexual relationships. J Ir Med Assoc (1972) 1.89
Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 1.88
NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology (Williston Park) (2000) 1.88
A promoter mutation in the XIST gene in two unrelated families with skewed X-chromosome inactivation. Nat Genet (1997) 1.88
A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol (1990) 1.86
A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases. Am J Hum Genet (1994) 1.84
Activated transcription independent of the RNA polymerase II holoenzyme in budding yeast. Genes Dev (1998) 1.83
The red queen reigns in the kingdom of RNA viruses. Proc Natl Acad Sci U S A (1994) 1.83
Microtubule behavior during guidance of pioneer neuron growth cones in situ. J Cell Biol (1991) 1.83
Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med (1979) 1.81
Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol (1998) 1.80
Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science (1987) 1.80
Linking the Rb and polycomb pathways. Mol Cell (2001) 1.76
Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial congenital heart disease. Hum Mol Genet (1993) 1.76
Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group. N Engl J Med (1999) 1.75
Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg (2002) 1.74
Extended analysis of the in vitro tropism of porcine endogenous retrovirus. J Virol (2000) 1.74
Patterns of walker use and walker injury. Pediatrics (1986) 1.73
Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys (1998) 1.72
Percutaneous gastrostomy with fluoroscopic guidance: single-center experience in 500 consecutive cancer patients. Radiology (1999) 1.70
Transcriptional regulation of oxytocin receptor by interleukin-1beta and interleukin-6. Endocrinology (2001) 1.65
Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg (1995) 1.64
Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology (2011) 1.64
Molecular characterization of bovine enteric caliciviruses: a distinct third genogroup of noroviruses (Norwalk-like viruses) unlikely to be of risk to humans. J Virol (2003) 1.64
Radiofrequency liver ablation: experimental comparative study of water-cooled versus expandable systems. AJR Am J Roentgenol (2001) 1.61
Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend (1999) 1.60
Attitudes and beliefs about organ donation among different racial groups. J Natl Med Assoc (1998) 1.60
Creating a Drosophila wing de novo, the role of engrailed, and the compartment border hypothesis. Development (1995) 1.59
Doppler US with perfusion software and contrast medium injection in the early evaluation of isolated limb perfusion of limb sarcomas: prospective study of 49 cases. Ann Oncol (2005) 1.59
The importance of school and social activities in the transmission of influenza A(H1N1)v: England, April - June 2009. Euro Surveill (2009) 1.54
Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer (1999) 1.53
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J (2005) 1.53
Pioneer growth cone steering decisions mediated by single filopodial contacts in situ. J Neurosci (1990) 1.52
Mutational analysis of acute-phase response factor/Stat3 activation and dimerization. Mol Cell Biol (1997) 1.51
Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers. Tob Control (2004) 1.47
Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome. Am J Hum Genet (1993) 1.47
Metal-dependent binding of a factor in vivo to the metal-responsive elements of the metallothionein 1 gene promoter. Mol Cell Biol (1987) 1.47
Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J (2005) 1.47
Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology (1996) 1.46
The second-look operation improves survival in suboptimally debulked stage III ovarian cancer patients. Int J Gynecol Cancer (2005) 1.46
Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med (1996) 1.46
[Percutaneous radiofrequency ablation of hepatic metastases. Preliminary experience]. Gastroenterol Clin Biol (1999) 1.45